Insulet Corp
(FRA:GOV)
€
250.4
24.9 (11.04%)
Market Cap: 17.41 Bil
Enterprise Value: 17.87 Bil
PE Ratio: 45.89
PB Ratio: 16.81
GF Score: 90/100 Insulet Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 10, 2021 / 05:15PM GMT
Release Date Price:
€248.8
(-3.15%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good afternoon, and thank you for joining us for the second day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the healthcare research team here at Morgan Stanley.
It's my pleasure to have Insulet with us today, Shacey Petrovic, President and CEO; and Deb Gordon, Vice President, IR.
Before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, Shacey, Deb, thank you for joining us today.
Shacey Petrovic
Insulet Corporation - President, CEO & Director
Thanks, Cecilia. Great to be here with you.
Deborah R. Gordon
Insulet Corporation - VP of IR
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot